Genesis Research Group is one of the leading evidence generation consultancies providing agile, tech-enabled real-world evidence (RWE), as well as health economics and outcomes research (HEOR) solutions to clients in the pharmaceutical, biotech, and medical device industries. Since 2009, we’ve partnered with our clients to develop impactful evidence across the product lifecycle to optimize market access for novel healthcare innovations and satisfy regulatory, provider, and payer evidence requirements. Genesis Research Group is database agnostic, regularly working across many structured and unstructured real-world data sources. As a company, we deliver services across many RWE and HEOR applications and a wide range of therapeutic areas with an emphasis on uncompromising quality, scientific rigor, and flexible solutions.
The Genesis Evidence Synthesis (ES) team works exclusively on qualitative and, in collaboration with the Genesis Biostatistics and Analytics teams, quantitative evidence synthesis activities. Our work includes systematic, structured, and targeted literature reviews, as well as meta-analysis, meta-regression, and indirect treatment comparisons (e.g. network meta-analysis [NMA], matching adjusted indirect comparisons [MAIC], etc.). The team works collaboratively with clients, their external stakeholders, and our broad team of internal experts to efficiently deliver rigorous research findings supporting varying needs in the pharmaceutical industry – competitive intelligence activities, database landscape assessments, disease and health economic modelling inputs, dossier development, internal strategy support, gap analysis, publications, HTA/payer/reimbursement submissions, regulatory submissions, and more. The Genesis team has decades of combined experience, including a strong record of peer-reviewed publications and work in evidence synthesis.
Flexible – Hybrid or Remote, depending on location.